Table 1.
Cancer type | MicroRNAsa | Ref. |
---|---|---|
Breast | ||
ER status | miR-26a/b, miR-30 family, miR-29b, miR-155, miR-342, miR-206, miR-191 |
[38–40, 42] |
PR status | let-7c, miR-29b, miR-26a, miR-30 family, miR-520g |
[41, 42] |
Her2/neu status | miR-520d, miR-181c, miR-302c, miR-376b, miR-30e |
[38, 41] |
Lung | ||
squamous vs non-squamous cell | miR-205 | [33] |
small cell vs non-small cell | miR-17-5p, miR-22, miR-24, miR-31 |
[32] |
Gastric | ||
diffuse vs intestinal | miR-29b/c, miR-30 family, miR-135a/b |
[35] |
Endometrial | ||
endometrioid vs uterine papillary | miR-19a/b, miR-30e-5p, miR-101, miR-452, miR-382, miR-15a, miR-29c |
[37] |
Renal | ||
clear cell vs papillary | miR-424, miR-203, miR-31, miR-126 |
[34, 36] |
oncocytoma vs chromophobe | miR-200c, miR-139-5p | [36] |
Myeloma | ||
with t(14;16) | miR-1, miR-133a | [60] |
with t(4;14) | miR-203, miR-155, miR-375 | [60] |
with t(11;14) | miR-125a, miR-650, miR-184 | [60] |
Acute myeloid leukemia | ||
with t(15;17) | miR-382, miR-134, miR-376a, miR-127, miR-299-5p, miR-323 |
[52] |
with t(8;21) orf inv(16) | let-7b/c, miR-127 | [52] |
with NPM1b mutations | miR-10a/b, let-7, miR-29, miR-204, miR-128a, miR-196a/b |
[51, 52] |
with FLT3 ITD | miR-155 | [51, 52, 54] |
Chronic lymphocytic leukemia | ||
ZAP-70 levels and IgVH status | miR-15a, miR-195, miR-221, miR-155, miR-23b |
[50] |
Melanoma | ||
with BRAF V600E | miR-193a, miR-338, miR-565 | [56] |
Not all distinguishing microRNAs are represented in this table
nucleophosmin1